Evolution of Myocardial Dysfunction in Asymptomatic Patients at Risk of Heart Failure.

JACC. Cardiovascular Imaging
Amera HalabiThomas H Marwick

Abstract

The determinants of changes in systolic and diastolic parameters in patients age >65 years, at risk of heart failure (HF), and with and without asymptomatic type 2 diabetes mellitus (T2DM) was assessed by echocardiography. The association between metformin and myocardial function was also assessed. The increasing prevalence of T2DM will likely further fuel the epidemic of HF. Understanding the development or progression of left ventricular (LV) dysfunction may inform effective measures for HF prevention. A total of 982 patients with at least one HF risk factor (hypertension, obesity, or T2DM) were recruited from 2 community-based populations and divided into 2 groups: T2DM (n = 431, age 71 ± 4 years) and non-T2DM (n = 551, age 71 ± 5 years). Associations of metformin therapy were evaluated in the T2DM group. All underwent a comprehensive echocardiogram, including global longitudinal strain (GLS) and diastolic function (transmitral flow [E], annular velocity [e']) at baseline and follow-up (median 19 months [interquartile range: 17 to 26 months]). Comparisons were facilitated by propensity matching. A reduction in GLS was observed in the T2DM group (baseline -17.8 ± 2.6% vs. follow-up -17.4 ± 2.8%; p = 0.003), but not in the non...Continue Reading

References

May 1, 1987·Diabetes·R A JacksonA B Kurtz
Feb 23, 2000·Journal of Cardiovascular Pharmacology and Therapeutics·G N JyothirmayiT J Regan
Jun 14, 2002·American Journal of Physiology. Heart and Circulatory Physiology·Takayuki SaitoAdel Giaid
May 6, 2003·The American Journal of Cardiology·Maria FrigerioRobert O Bonow
Aug 13, 2003·Circulation·Thomas J WangRamachandran S Vasan
Jan 4, 2007·Diabetes, Obesity & Metabolism·D P MacfarlaneM Fisher
Jun 27, 2007·Circulation·Sihem Boudina, E Dale Abel
Jun 6, 2008·Diabetologia·C J BaileyJ H B Scarpello
Mar 9, 2010·Journal of Cardiac Failure·Digish D ShahTamara B Horwich
Nov 26, 2010·Archives of Internal Medicine·Ronan RousselUNKNOWN Reduction of Atherothrombosis for Continued Health (REACH) Registry Investigators
Apr 25, 2015·Diabetes & Vascular Disease Research : Official Journal of the International Society of Diabetes and Vascular Disease·Carolyn Sp Lam
Nov 5, 2016·European Journal of Heart Failure·Hong YangThomas H Marwick
Sep 30, 2017·Journal of the American College of Cardiology·Laura ErnandeGeneviève Derumeaux
May 12, 2018·Circulation Research·Edoardo Bertero, Christoph Maack
Sep 27, 2018·International Journal of Molecular Sciences·Aleksandra DziubakJerzy Bełtowski
Dec 21, 2018·The Journal of General Physiology·Rebecca E SlaterHenk L Granzier
May 9, 2019·Journal of Cardiovascular Pharmacology and Therapeutics·Aparna P SajjaAnkur Kalra
Sep 10, 2019·European Heart Journal·Francesco CosentinoUNKNOWN ESC Scientific Document Group

❮ Previous
Next ❯

Citations

Jan 18, 2021·JACC. Cardiovascular Imaging·Barry A Borlaug, Hidemi Sorimachi

❮ Previous
Next ❯

Related Concepts

Related Feeds

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.